BPC-157 5mg + TB-500 5mg (blend)

The BPC-157 + TB-500 blend combines two of the most-studied regenerative peptides in preclinical research in a single reconstitutable vial that simplifies administration without losing efficacy. Each 10 mg vial contains 5 mg of BPC-157 and 5 mg of TB-500 (Thymosin Beta-4 fragment).

The combination is not arbitrary: the two peptides act on different but complementary fronts of the tissue repair process. BPC-157 stimulates new tissue formation and modulates local inflammation, while TB-500 promotes angiogenesis and fibroblast migration to the injured site.

BPC-157 (Body Protection Compound 157):

15-amino-acid pentadecapeptide derived from a protective gastric protein. Stimulates endothelial nitric oxide production, promotes local angiogenesis, and accelerates the healing of tendons, ligaments, and gastrointestinal mucosa. Acts by modulating the nitric oxide system, the VEGFR2 pathway, and expression of genes related to the extracellular matrix.

TB-500 (Thymosin Beta-4 fragment):

Active analog of Thymosin Beta-4. Its main function is to regulate actin, the protein that organizes the cellular cytoskeleton. This regulation allows cells to migrate to the injury site, form new blood vessels (angiogenesis), and rebuild the damaged extracellular matrix.

Sinergia documentada:

While BPC-157 accelerates the first repair phase (inflammation control, cellular recruitment), TB-500 covers the secondary phase (sustained angiogenesis, matrix remodeling). Combined, they cover the full arc of the healing process.

• Lesiones tendinosas y ligamentarias (tendinitis, epicondilitis, lesiones de manguito rotador)
• Lesiones musculares por sobrecarga deportiva
• Post-surgical orthopedic recovery
• Carpal tunnel syndrome and peripheral nerve injuries
• Cardiac recovery post-ischemic event (preclinical research)
• Skin and mucosal healing

Reconstitution: add 2 ml of bacteriostatic water to the 10 mg blend vial. Resulting concentration: 5,000 mcg/ml combined (2,500 mcg of each peptide per ml).

Benign profile in preclinical studies. TB-500 has a mild antiplatelet effect: discontinue 48 hours before any surgical procedure. Relative contraindication in active tumors due to pro-angiogenic potential.

• Full athletic recovery: BPC+TB blend + CJC No DAC + Ipamorelin for GH support during repair
• Post-trasplante capilar: blend + GHK-Cu for regenerative synergy of graft + follicle
• Intestino + articular: blend + KPV to cover systemic and mucosal inflammation

1. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157 and its role in healing of gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632.
2. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429.
3. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780.